NPPB and type 2 diabetes mellitus: As we only had access to de-identified leftover patient sera, we were unable to determine how being overweight/obese and having type 2 diabetes mellitus was operative in our study participants, nor could we determine their impact on the Abbott NT-proBNP assay.